Mesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 11, 2016, Pages H1816-H1826

  Wehman, Brody ^a   Sharma, Sudhish ^a   Pietris, Nicholas ^a   Mishra, Rachana ^a   Siddiqui, Osama T ^a   Bigham, Grace ^a   Li, Tieluo ^a   Aiello, Emily ^a   Murthi, Sarah ^a   Pittenger, Mark ^a   Griffith, Bartley ^a   Kaushal, Sunjay ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Congenital heart disease; Pressure overload; Right ventricle; Stem cell therapy

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; GROWTH DIFFERENTIATION FACTOR 15; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; SMAD2 PROTEIN; SMAD3 PROTEIN; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; MYOSIN HEAVY CHAIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL PROLIFERATION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; GENE EXPRESSION; HEART LEFT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; LUNG ARTERY BANDING; MESENCHYMAL STEM CELL TRANSPLANTATION; NEWBORN; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; RAT; YORKSHIRE PIG; ANIMAL; DISEASE MODEL; HEART VENTRICLE PRESSURE; HYPERTROPHY, RIGHT VENTRICULAR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; NATRIURETIC PEPTIDE, BRAIN; SWINE; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 84983789342     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00955.2015     Document Type: Article

References (41)

1. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with in-tramyocardial injection of allogeneic mesenchymal stem cells after myo-cardial infarction. Proc Natl Acad Sci U S A 102: 11474–11479, 2005.
2. Aoki H, Sadoshima J, Izumo S. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat Med 6: 183–188, 2000.
3. Boomsma RA, Geenen DL. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PloS One 7: e35685, 2012.
4. Burns KM, Byrne BJ, Gelb BD, Kuhn B, Leinwand LA, Mital S, Pearson GD, Rodefeld M, Rossano JW, Stauffer BL, Taylor MD, Towbin JA, Redington AN. New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group. Circulation 130: 79–86, 2014.
5. Chowdhury SM, Hijazi ZM, Rhodes JF, Kar S, Makkar R, Mullen M, Cao QL, Mandinov L, Buckley J, Pietris NP, Shirali GS. Changes in speckle tracking echocardiography measures of ventricular function after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position. Echocardiography 32: 461–469, 2015.
6. Davies B, Elwood NJ, Li S, Cullinane F, Edwards GA, Newgreen DF, Brizard CP. Human cord blood stem cells enhance neonatal right ven-tricular function in an ovine model of right ventricular training. Ann Thorac Surg 89: 585–593, 2010.
7. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204–1219, 2008.
8. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 117: 1717–1731, 2008.
9. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117: 1436–1448, 2008.
10. Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zam-brano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A. Comparison of allogeneic vs autologous bone marrow-derived mesen-chymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308: 2369–2379, 2012.
11. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult hu-man mesenchymal stem cells (prochymal) after acute myocardial infarc-tion. J Am Coll Cardiol 54: 2277–2286, 2009.
12. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, Mazhari R, Boyle AJ, Zambrano JP, Rodriguez JE, Dulce R, Pattany PM, Valdes D, Revilla C, Heldman AW, McNiece I, Hare JM. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107: 913–922, 2010.
13. Hou L, Kim JJ, Woo YJ, Huang NF. Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease. Am J Physiol Heart Circ Physiol 310: H455–H465, 2016.
14. Huntsman HD, Zachwieja N, Zou K, Ripchik P, Valero MC, De Lisio M, Boppart MD. Mesenchymal stem cells contribute to vascular growth in skeletal muscle in response to eccentric exercise. Am J Physiol Heart Circ Physiol 304: H72–H81, 2013.
15. Ishikawa K, Ladage D, Takewa Y, Yaniz E, Chen J, Tilemann L, Sakata S, Badimon JJ, Hajjar RJ, Kawase Y. Development of a preclinical model of ischemic cardiomyopathy in swine. Am J Physiol Heart Circ Physiol 301: H530–H537, 2011.
16. Jansen Of Lorkeers SJ, Hart E, Tang XL, Chamuleau ME, Doeven-dans PA, Bolli R, Chamuleau SA. Cyclosporin in cell therapy for cardiac regeneration. J Cardiovasc Transl Res 7: 475–482, 2014.
17. Kantor PF, Redington AN. Pathophysiology and management of heart failure in repaired congenital heart disease. Heart Fail Clin 6: 497–506, 2010.
18. Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM. Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol 303: H256–H270, 2012.
19. Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zam-brano JP, Fishman J, Pattany P, McNiece I, Conte J, Schulman S, Wu K, Shah A, Breton E, Davis-Sproul J, Schwarz R, Feigenbaum G, Mushtaq M, Suncion VY, Lardo AC, Borrello I, Mendizabal A, Karas TZ, Byrnes J, Lowery M, Heldman AW, Hare JM. Autologous mes-enchymal stem cells produce concordant improvements in regional func-tion, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res 114: 1302–1310, 2014.
20. Karantalis V, Schulman IH, Balkan W, Hare JM. Allogeneic cell therapy: a new paradigm in therapeutics. Circ Res 116: 12–15, 2015.
21. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, Landzberg MJ. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117: 85–92, 2008.
22. Kohler D, Arnold R, Loukanov T, Gorenflo M. Right ventricular failure and pathobiology in patients with congenital heart disease—implications for long-term follow-up. Front Pediatr 1: 37, 2013.
23. Lee TM, Aiyagari R, Hirsch JC, Ohye RG, Bove EL, Devaney EJ. Risk factor analysis for second-stage palliation of single ventricle anatomy. Ann Thorac Surg 93: 614–618, 2012.
24. Li T, Wei X, Watkins AC, Sanchez PG, Wu ZJ, Griffith BP. Prophy-lactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. J Surg Res 185: 152–158, 2013.
25. Lopez L, Cohen MS, Anderson RH, Redington AN, Nykanen DG, Penny DJ, Deanfield JE, Eidem BW. Unnatural history of the right ventricle in patients with congenitally malformed hearts. Cardiol Young 20 Suppl 3: 107–112, 2010.
26. Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt PC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro C, Kanter KR, Jaggers J, Jacobs JP, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW, Pediatric Heart Network Investigators. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362: 1980–1992, 2010.
27. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 105: 1189–1194, 2002.
28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147, 1999.
29. Rossano JW, Shaddy RE. Heart failure in children: etiology and treat-ment. J Pediatr 165: 228–233, 2014.
30. Rossano JW, Shaddy RE. Update on pharmacological heart failure therapies in children: do adult medications work in children and if not, why not? Circulation 129: 607–612, 2014.
31. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chan-drasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Asso-ciation of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23: 685–713, 2010.
32. Selem SM, Kaushal S, Hare JM. Stem cell therapy for pediatric dilated cardiomyopathy. Curr Cardiol Rep 15: 369, 2013.
33. Simpson DL, Mishra R, Sharma S, Goh SK, Deshmukh S, Kaushal S. A strong regenerative ability of cardiac stem cells derived from neonatal hearts. Circulation 126: S46–53, 2012.
34. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward JB. Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. J Am Coll Cardiol 36: 472–478, 2000.
35. Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, Anversa P. Myocardial regeneration by activation of multi-potent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 102: 8692–8697, 2005.
36. Waspe LE, Ordahl CP, Simpson PC. The cardiac -myosin heavy chain isogene is induced selectively in 1-adrenergic receptor-stimulated hy-pertrophy of cultured rat heart myocytes. J Clin Invest 85: 1206–1214, 1990.
37. Wehman B, Kaushal S. The emergence of stem cell therapy for patients with congenital heart disease. Circ Res 116: 566–569, 2015.
38. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127: 213–223, 2013.
39. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98: 342–350, 2006.
40. Xu XY, Nie Y, Wang FF, Bai Y, Lv ZZ, Zhang YY, Li ZJ, Gao W. Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation. J Biol Chem 289: 10084–10094, 2014.
41. Zhao Y, Li T, Wei X, Bianchi G, Hu J, Sanchez PG, Xu K, Zhang P, Pittenger MF, Wu ZJ, Griffith BP. Mesenchymal stem cell transplan-tation improves regional cardiac remodeling following ovine infarction. Stem Cells Transl Med 1: 685–695, 2012.